Research Summary
Research Summary
03/25/2025
Kate Young
A new study found that therapy dogs reduce anxiety in children visiting the emergency department, with both child-reported and parent-reported anxiety scores decreasing more in those who interacted with a...
03/25/2025
Research Summary
Research Summary
02/14/2025
Kate Young
A recent study suggests that an 8-week online mindfulness program may help alleviate dyspnea in patients with interstitial lung disease, a condition often resistant to conventional treatments.
02/14/2025
Research Summary
Research Summary
12/02/2024
Miranda Manier, BA
A randomized, placebo-controlled trial found that executive working memory training leads to significant behavioral improvements in adolescents with attention-deficit/hyperactivity disorder.
12/02/2024
FDA Alert
FDA Alert
09/30/2024
Miranda Manier, BA
Two randomized, double-blind studies demonstrated that a new antipsychotic treatment for adult patients with schizophrenia may lead to a meaningful reduction in symptoms.
09/30/2024
Research summary
Research summary
08/15/2024
Jessica Ganga
Researchers sought to evaluate the risk of patients newly diagnosed with alopecia areata developing psychiatric or autoimmune disease after diagnosis.
08/15/2024
Research summary
Research summary
05/23/2024

Jessica Ganga

Jessica Ganga
A team of researchers examined the possibility of harmful risks associated with the discontinuation of long-term benzodiazepine use in patients.
05/23/2024
research summary
research summary
03/11/2024

Leigh Precopio

Leigh Precopio
Researchers examined how the availability of mental health services and patient specific characteristics impacted levels of anxiety and depression in residents of long-term care settings following COVID-19...
03/11/2024
research summary
research summary
03/01/2024

Jessica Ganga

Jessica Ganga
Researchers examined the characteristics and trends related to the increased mortality rates associated with overdose in pregnant and postpartum women.
03/01/2024
FDA Alert
FDA Alert
10/04/2023
Jessica Ganga
Following two randomized studies, the FDA has approved zuranolone for the treatment of postpartum depression in adults—the first if its kind.
10/04/2023
Research summary
Research summary
07/28/2023
Jessica Ganga
The USPSTF has updated its recommendations on screening adults for major depressive disorder (MDD) and suicide risk.
07/28/2023